Neurocrine Biosciences reported $1.65 in EPS Earnings Per Share for its fiscal quarter ending in June of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q3 Sep/2025 1.56 1.81 Nov/04 2025
FY2025Q2 Jun/2025 1.65 0.98 1.63 Jul/30 2025
FY2025Q1 Mar/2025 0.70 0.86 1.20 May/05 2025
FY2024Q4 Dec/2024 1.69 1.57 1.54 Feb/06 2025
FY2024Q3 Sep/2024 1.81 1.52 1.54 Oct/30 2024
FY2024Q2 Jun/2024 1.63 1.13 0.95 Aug/01 2024
FY2024Q1 Mar/2024 1.20 1.07 -0.79 May/01 2024
FY2023Q4 Dec/2023 1.54 1.21 0.88 Feb/07 2024
FY2023Q3 Sep/2023 1.54 1.05 0.69 Oct/31 2023
FY2023Q2 Jun/2023 0.95 0.83 -0.18 Aug/01 2023
FY2023Q1 Mar/2023 -0.79 -0.53 0.14 May/03 2023
FY2022Q4 Dec/2022 0.88 1.11 -0.08 Feb/06 2023


Eps Change Date
AbbVie USD 2.97 0.51 Jun/2025
Acadia Pharmaceuticals USD 0.16 0.05 Jun/2025
Agios Pharmaceuticals USD -1.93 0.38 Jun/2025
ALKERMES USD 0.52 0.39 Jun/2025
Alnylam Pharmaceuticals USD 0.32 0.33 Jun/2025
Amgen USD 6.02 1.12 Jun/2025
Biogen USD 5.47 2.45 Jun/2025
BioMarin Pharmaceutical USD 1.44 0.31 Jun/2025
Cytokinetics USD -1.12 0.24 Jun/2025
Dynavax Technologies USD 0.14 0.91 Jun/2025
Exelixis USD 0.75 0.13 Jun/2025
Gilead Sciences USD 2.01 0.2 Jun/2025
Halozyme Therapeutics USD 1.54 0.43 Jun/2025
Incyte USD 1.57 0.41 Jun/2025
Ionis Pharmaceuticals USD 0.7 1.63 Jun/2025
Neurocrine Biosciences USD 1.65 0.95 Jun/2025
Pfizer USD 0.78 0.14 Jun/2025
Prothena USD -2.34 1.26 Jun/2025
Regeneron Pharmaceuticals USD 12.89 4.67 Jun/2025
Repligen USD 0.37 0.02 Jun/2025
Sarepta Therapeutics USD 2.02 5.44 Jun/2025
Teva Pharmaceutical Industries USD 2.22 0.34 Jun/2025
Ultragenyx Pharmaceutical USD -1.17 0.4 Jun/2025
Vertex Pharmaceuticals USD 4.52 0.46 Jun/2025